Showing 101 - 120 of 178 results
Association recognises contribution to neutron scattering
International neutron scattering award for retired head of former Bragg Institute, Prof Robert Robinson
Earth-based research link to International Space Station
Neutron scattering instruments used by Japanese researchers.
New beamline provides state-of-the-art imaging capability
The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.
Pioneering collaboration advances nuclear medicine
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Fine particle pollution peaks during bushfires
Recent catastrophic Australian bushfires produced extremely high levels of fine particle pollution.
New antibody-like molecule which could be used in therapy to prevent infection from multiple forms of malaria
The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.
ANSTO supports innovative industry process to minimise plastic waste and maximise feed stock for 3D printing
Understanding fine particle pollution
Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.
Association award to neutron scientist
Professor Vanessa Peterson, Senior Principal Research and Neutron Scattering Instrument Scientist and Leader of the Energy Materials Research project, has been awarded the Bob Cheary Award or Excellence in Diffraction Analysis by the Australian X-ray Analytical Association. She is the first female to be chosen for the award.
New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.
Synchrotron light reveals secrets of mystery McCubbin
Fine-tuning chemistry for advanced materials
Doping with transition metals produced stability in bismuth oxide.
Fine-tuning chemistry
Doping with transition metals produced stability in bismuth oxide.
$12.5 million for new jobs from ANSTO’s Innovation Precinct
The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).
Research brings new insights to the complex immune response in the brain
Data analysis - XFM beamline
Data analysis on the X-ray fluorescence microscopy beamline at the Australian Synchrotron.